No retraction, correction or concern found when last checked on Oct 30, 2026.
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Barry Rockx, Thijs Kuiken, Sander Herfst and 21 more
Science · 2020
Abstract
Coronavirus in nonhuman primates We urgently need vaccines and drug treatments for coronavirus disease 2019 (COVID-19). Even under these extreme circumstances, we must have animal models for rigorous testing of new strategies. Rockx et al. have undertaken a comparative study of three human coronaviruses in cynomolgus macaques: severe acute respiratory syndrome–coronavirus (SARS-CoV) (2002), Middle East respiratory syndrome (MERS)–CoV (2012), and SARS-CoV-2 (2019), which causes COVID-19 (see the Perspective by Lakdawala and Menachery). The most recent coronavirus has a distinct tropism for the nasal mucosa but is also found in the intestinal tract. Although none of the older macaques showed the severe symptoms that humans do, the lung pathology observed was similar. Like humans, the animals shed virus for prolonged periods from their upper respiratory tracts, and like influenza but unlike the 2002 SARS-CoV, this shedding peaked early in infection. It is this cryptic virus shedding that makes case detection difficult and can jeopardize the effectiveness of isolation. Science , this issue p. 1012 ; see also p. 942
References 30
- 1.
Chan J. F., Yuan S., Kok K.-H., To K. K.-W., Chu H., Yang J., Xing F., Liu J., Yip C. C.-Y., Poon R. W.-S., Tsoi H.-W., Lo S. K.-F., Chan K.-H., Poon V. K.-M., Chan W.-M., Ip J. D., Cai J.-P., Cheng V. C.-C., Chen H., Hui C. K.-M., Yuen K.-Y., A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 395, 514–523 (2020 ).
Not in our library10.1016/s0140-6736(20)30154-9
- 2.
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020 ).
Not in our library10.1016/s0140-6736(20)30183-5
- 3.
Mahase E., Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ 368, m641 (2020 ).
Not in our library10.1136/bmj.m641
- 4.
Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J., Fan Y., Zheng C., Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect. Dis. 20, 425–434 (2020 ).
Not in our library10.1016/s1473-3099(20)30086-4
- 5.
Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395, 507–513 (2020 ).
Not in our library10.1016/s0140-6736(20)30211-7
- 6.
Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., Dong J., Zhao J., Wang F.-S., Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420–422 (2020 ).
Not in our library10.1016/s2213-2600(20)30076-x
- 7.
Tian S., Hu W., Niu L., Liu H., Xu H., Xiao S.-Y., Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J. Thorac. Oncol. S1556-0864(20)30132-5 (2020 ).
Not in our library10.1016/j.jtho.2020.02.010
- 8.
Nicholls J. M., Poon L. L. M., Lee K. C., Ng W. F., Lai S. T., Leung C. Y., Chu C. M., Hui P. K., Mak K. L., Lim W., Yan K. W., Chan K. H., Tsang N. C., Guan Y., Yuen K. Y., Peiris J. S., Lung pathology of fatal severe acute respiratory syndrome. Lancet 361, 1773–1778 (2003 ).
Not in our library10.1016/s0140-6736(03)13413-7
- 9.
Fouchier R. A., Kuiken T., Schutten M., van Amerongen G., van Doornum G. J. J., van den Hoogen B. G., Peiris M., Lim W., Stöhr K., Osterhaus A. D. M. E., Koch’s postulates fulfilled for SARS virus. Nature 423, 240 (2003 ).
Not in our library10.1038/423240a
- 10.
Kuiken T., Fouchier R. A. M., Schutten M., Rimmelzwaan G. F., van Amerongen G., van Riel D., Laman J. D., de Jong T., van Doornum G., Lim W., Ling A. E., Chan P. K. S., Tam J. S., Zambon M. C., Gopal R., Drosten C., van der Werf S., Escriou N., Manuguerra J.-C., Stöhr K., Peiris J. S. M., Osterhaus A. D. M. E., Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263–270 (2003 ).
Not in our library10.1016/s0140-6736(03)13967-0
- 11.
- 12.
Haagmans B. L., Kuiken T., Martina B. E., Fouchier R. A. M., Rimmelzwaan G. F., van Amerongen G., van Riel D., de Jong T., Itamura S., Chan K.-H., Tashiro M., Osterhaus A. D. M. E., Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10, 290–293 (2004 ).
Not in our library10.1038/nm1001
- 13.
Rockx B., Feldmann F., Brining D., Gardner D., LaCasse R., Kercher L., Long D., Rosenke R., Virtaneva K., Sturdevant D. E., Porcella S. F., Mattoon J., Parnell M., Baric R. S., Feldmann H., Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques. PLOS ONE 6, e18558 (2011 ).
Not in our library10.1371/journal.pone.0018558
- 14.
- 15.
- 16.
Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., Yu J., Kang M., Song Y., Xia J., Guo Q., Song T., He J., Yen H.-L., Peiris M., Wu J., SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N. Engl. J. Med. 382, 1177–1179 (2020 ).
Not in our library10.1056/nejmc2001737
- 17.
Peiris J. S., Chu C. M., Cheng V. C. C., Chan K. S., Hung I. F. N., Poon L. L. M., Law K. I., Tang B. S. F., Hon T. Y. W., Chan C. S., Chan K. H., Ng J. S. C., Zheng B. J., Ng W. L., Lai R. W. M., Guan Y., Yuen K. Y.; HKU/UCH SARS Study Group, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet 361, 1767–1772 (2003 ).
Not in our library10.1016/s0140-6736(03)13412-5
- 18.
- 19.
- 20.
Pang X., Zhu Z., Xu F., Guo J., Gong X., Liu D., Liu Z., Chin D. P., Feikin D. R., Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003. JAMA 290, 3215–3221 (2003 ).
Not in our library10.1001/jama.290.24.3215
- 21.
Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H., Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology S0016-5085(20)30282-1 (2020 ).
Not in our library10.1053/j.gastro.2020.02.055
- 22.
W. D. Linlin Bao et al, Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. bioRxiv 2020.03.13.990226 (2020)..
Not in our library10.1101/2020.03.13.990226
- 23.
V. J. Munster et al, Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2. bioRxiv 2020.03.21.001628 (2020)..
Not in our library10.1101/2020.03.21.001628
- 24.
Ware L. B., Matthay M. A., The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334–1349 (2000 ).
Not in our library10.1056/nejm200005043421806
- 25.
Shieh W. J., Hsiao C.-H., Paddock C. D., Guarner J., Goldsmith C. S., Tatti K., Packard M., Mueller L., Wu M.-Z., Rollin P., Su I.-J., Zaki S. R., Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum. Pathol. 36, 303–309 (2005 ).
Not in our library10.1016/j.humpath.2004.11.006
- 26.
Ng D. L., Al Hosani F., Keating M. K., Gerber S. I., Jones T. L., Metcalfe M. G., Tong S., Tao Y., Alami N. N., Haynes L. M., Mutei M. A., Abdel-Wareth L., Uyeki T. M., Swerdlow D. L., Barakat M., Zaki S. R., Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014. Am. J. Pathol. 186, 652–658 (2016 ).
Not in our library10.1016/j.ajpath.2015.10.024
- 27.
Raj V. S., Mou H., Smits S. L., Dekkers D. H. W., Müller M. A., Dijkman R., Muth D., Demmers J. A. A., Zaki A., Fouchier R. A. M., Thiel V., Drosten C., Rottier P. J. M., Osterhaus A. D. M. E., Bosch B. J., Haagmans B. L., Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251–254 (2013 ).
Not in our library10.1038/nature12005
- 28.
Haagmans B. L., van den Brand J. M. A., Provacia L. B., Raj V. S., Stittelaar K. J., Getu S., de Waal L., Bestebroer T. M., van Amerongen G., Verjans G. M. G. M., Fouchier R. A. M., Smits S. L., Kuiken T., Osterhaus A. D. M. E., Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits. J. Virol. 89, 6131–6135 (2015 ).
Not in our library10.1128/jvi.00661-15
- 29.
- 30.
Cited by papers we hold 51
- Myeloid cell interferon responses correlate with clearance of SARS-CoV-2 · 2022Not checked
- Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19 · 2022Not checked
- Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo · 2021Not checked
- Hypoxia may be a determinative factor in COVID-19 progression · 2021Not checked
- Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2 · 2021No notice
- The total number and mass of SARS-CoV-2 virions · 2021No notice
- Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment · 2021No notice
- The Mechanisms and Animal Models of SARS-CoV-2 Infection · 2021Not checked
- Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates · 2021Not checked
- SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents · 2021No notice
- SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation · 2021No notice
- Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 · 2021No notice
- The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates · 2021No notice
- SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site · 2021No notice
- Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans · 2021No notice
- Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates · 2021No notice
- SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications · 2021No notice
- K18-hACE2 mice develop respiratory disease resembling severe COVID-19 · 2021No notice
- A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 · 2021No notice
- Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model · 2021No notice
and 31 more
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.